Task: Answer the MCQ question.
Question: Which drug exhibits a 22.486% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) Cc1ccc(CC2C(=O)N(c3ccc(C)cc3)C(=O)C2C)cc1
b.) Cc1cccc(NC(=O)Nc2cc(C)cc(C)n2)c1
c.) Cc1cc(NC(=O)CSc2nnc(C(C)N(C)C)n2-c2ccc(F)cc2)no1
d.) COc1ccc(CCNC(=O)CCCn2c(=O)c3cccn3c3cccnc32)c(OC)c1OC
e.) O=C(Nc1cccc(NC(=O)c2ccc(-c3cccc(Br)c3)o2)c1)c1ccco1
Answer: a. Cc1ccc(CC2C(=O)N(c3ccc(C)cc3)C(=O)C2C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(CC2C(=O)N(c3ccc(C)cc3)C(=O)C2C)cc1
Cc1ccc(CC2C(=O)N(c3ccc(C)cc3)C(=O)C2C)cc1
3-methyl-1-(4-methylphenyl)-4-[(4-methylphenyl)methyl]pyrrolidine-2,5-dione